Investigational drug · Phase 3
Lower sulfate eye drops
Also called: Lower sulfate
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Myopia.
Phase 3Last checked: Nov 19, 2026Latest source record: Jul 30, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "Lower sulfate eye drops"
First trial start
2022
Mar 15, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Lower sulfate eye drops", any sponsor or status.
Conditions studied
As listed on its trial records.
- Myopia
Largest trials
Live from ClinicalTrials.gov: studies naming "Lower sulfate eye drops" as an intervention, largest first.
- A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye DropsPivotal-lookingActive, not recruiting
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Industry
NCT06209320 · 777 participants (planned) · Start Mar 15, 2022 · Primary completion Mar 21, 2025
Drug: Lower dose atropine sulfate eye drops; Low dose atropine sulfate eye drops and 1 more · For: Myopia
Sites: Beijing, China
- A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye DropsPivotal-lookingActive, not recruiting
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Industry
NCT06209281 · 526 participants · Start May 13, 2022 · Primary completion Aug 20, 2023
Drug: Lower dose atropine sulfate eye drops; Low dose atropine sulfate eye drops and 1 more · For: Myopia
Sites: Shanghai, China
Newest research
PubMed records naming it or its code names, newest first.
- Fe-S-C spatial ordering in bioretention: nutrient removal, by-product trade-offs and depth-associated microbial patterns.
Li J, Hou L, Leghari SJ, et al. · J Environ Manage 2026
- Temperature robustness of sulfur and hydrogen autotrophic reduction systems for antimonate detoxification: Experiment and machine learning-driven evaluation.
He Q, Mao Y, Xie J, et al. · J Hazard Mater 2026
- Application of Seaweed-Derived Polysaccharides in Biocrust Technology: Ultrasound-Assisted Fucoidan Extraction from Laminaria digitata.
Savik I, Savik Gajik I, Palanački Male¡evik T, et al. · Mar Biotechnol (NY) 2026
- Enhancing the Catalytic Properties of a Novel Bifunctional κ-Carrageenanase through Spontaneous Self-Cyclization Based on the SpyTag/SpyCatcher System.
Wang Z, Chen S, Li Y, et al. · J Agric Food Chem 2026
- Long-term performance of a woodchip-based field-scale biofilter for arsenic removal from neutral mine drainage under cold climate.
Thevenot XM, Roy T, Pakostova E, et al. · Water Res 2026
- Valorization of agar extracted from Gelidium elegans via ultrasound-assisted extraction as potential film packaging by optimizing the incorporation of chitosan and curcumin.
Nozid NAC, Ibrahim NH, Yoshida A, et al. · Int J Biol Macromol 2025
Also in development for Myopia
- atropine sulfate eye dropsPhase 33 trials
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Myopia, Myopia Progression
- CTO0308Phase 31 trial
Taejoon Pharmaceutical Co., Ltd. · Myopia
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.